Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-08

Clinical Trial Update: Effects of Abatacept in Patients With Early Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating abatacept in patients with early rheumatoid arthritis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abatacept (abatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2019-04-08